This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.
Nidhi K. Parmar*,
Beauty A. Yadav,
Krinal A. Patel,
Disha J. Nagdev,
Bisojeet R. Khandai,
- Student, Department of Pharmacy Practice, Maliba Pharmacy College, Uka Tarsadia University, Bardoli, Gujarat 394350, India
- Student, Department of Pharmacy Practice, Maliba Pharmacy College, Uka Tarsadia University, Bardoli, Gujarat 394350, India
- Student, Department of Pharmacy Practice, Maliba Pharmacy College, Uka Tarsadia University, Bardoli, Gujarat 394350, India
- Student, Department of Pharmacy Practice, Maliba Pharmacy College, Uka Tarsadia University, Bardoli, Gujarat 394350, India
- Student, Department of Pharmacy Practice, Maliba Pharmacy College, Uka Tarsadia University, Bardoli, Gujarat 394350, India
Abstract
Stem cell therapy has come up as a revolutionary technique in regenerative medicine living up to the promise in treating numerous diseases and injuries. The latest discoveries made in the field of stem cell research such as the introduction of gene editing technology like CRISPR and the creation of the 3D bioprinting process have increased the accuracy and efficacy of stem cell-based therapies. Examples include cardiac regeneration and repair of the nervous system, and degenerative conditions, including Parkinson and osteoarthritis. Moreover, personalized medicine and induced pluripotent stem cells (iPSCs) are setting the stage of patient-specific treatment with the lowest chance of immune rejection. But obstacles like ethical issues, risk of safety, and regulation are still there. In the future, stem cell therapy promises to be very useful in cancer treatment, and tissue engineering. Further research and innovation are likely to address such challenges and eventually transform the treatment process of complex diseases and patient outcomes.
Keywords: Stem cell therapy, regenerative medicine, CRISPR, 3D bioprinting, personalized medicine, induced pluripotent stem cells, cancer treatment, tissue engineering.
Nidhi K. Parmar*, Beauty A. Yadav, Krinal A. Patel, Disha J. Nagdev, Bisojeet R. Khandai. Stem Cell Therapy: Advancements, Applications, and Future Prospects in Regenerative Medicine. International Journal of Cell Biology and Cellular Functions. 2026; 04(01):-.
Nidhi K. Parmar*, Beauty A. Yadav, Krinal A. Patel, Disha J. Nagdev, Bisojeet R. Khandai. Stem Cell Therapy: Advancements, Applications, and Future Prospects in Regenerative Medicine. International Journal of Cell Biology and Cellular Functions. 2026; 04(01):-. Available from: https://journals.stmjournals.com/ijcbcf/article=2026/view=239661
References
1. Hussen BM, Taheri M, Yashooa RK, Abdullah GH, Abdullah SR, Kheder RK, et al. Revolutionizing medicine: recent developments and future prospects in stem-cell therapy. International Journal of Surgery. 2024;110(12):8002-24.
2. Mahla RS. Stem cells applications in regenerative medicine and disease therapeutics. International journal of cell biology. 2016;2016(1):6940283.
3. Mimeault M, Hauke R, Batra SK. Stem cells: A revolution in therapeutics—Recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clinical Pharmacology & Therapeutics. 2007;82(3):252-64.
4. Liu G, David BT, Trawczynski M, Fessler RG. Advances in pluripotent stem cells: history, mechanisms, technologies, and applications. Stem cell reviews and reports. 2020;16(1):3-32.
5. Omole AE, Fakoya AOJ. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications. PeerJ. 2018;6:e4370.
6. Shi Y, Inoue H, Wu JC, Yamanaka S. Induced pluripotent stem cell technology: a decade of progress. Nature reviews Drug discovery. 2017;16(2):115-30.
7. Golpanian S, Wolf A, Hatzistergos KE, Hare JM. Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiological reviews. 2016;96(3):1127-68.
8. Abdelwahid E, Kalvelyte A, Stulpinas A, De Carvalho KAT, Guarita-Souza LC, Foldes G. Stem cell death and survival in heart regeneration and repair. Apoptosis. 2016;21(3):252-68.
9. Yu H, Lu K, Zhu J, Wang Ja. Stem cell therapy for ischemic heart diseases. British medical bulletin. 2017;121(1):135-54.
10. Terashvili M, Bosnjak ZJ. Stem cell therapies in cardiovascular disease. Journal of cardiothoracic and vascular anesthesia. 2019;33(1):209-22.
11. Bernstein HS, Srivastava D. Stem cell therapy for cardiac disease. Pediatric research. 2012;71(2):491-9.
12. Laflamme MA, Murry CE. Heart regeneration. Nature. 2011;473(7347):326-35.
13. Ratcliffe E, Glen KE, Naing MW, Williams DJ. Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies. British medical bulletin. 2013;108(1):73-94.
14. Trounson A, Thakar RG, Lomax G, Gibbons D. Clinical trials for stem cell therapies. BMC medicine. 2011;9(1):52.
15. Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell stem cell. 2015;17(1):11-22.
16. Hoang DM, Pham PT, Bach TQ, Ngo AT, Nguyen QT, Phan TT, et al. Stem cell-based therapy for human diseases. Signal transduction and targeted therapy. 2022;7(1):272.
17. Ghosh D, Mehta N, Patil A, Sengupta J. Ethical issues in biomedical use of human embryonic stem cells (hESCs). Journal of Reproductive Health and Medicine. 2016;2:S37- S47.
18. Lysaght T, Kerridge IH, Sipp D, Porter G, Capps BJ. Ethical and regulatory challenges with autologous adult stem cells: a comparative review of international regulations. Journal of Bioethical Inquiry. 2017;14(2):261-73.
19. Zeng C-W. Advancing spinal cord injury treatment through stem cell therapy: a comprehensive review of cell types, challenges, and emerging technologies in regenerative medicine. International journal of molecular sciences. 2023;24(18):14349.
20. Nirmalanandhan VS, Sittampalam GS. Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges. Journal of biomolecular screening. 2009;14(7):755-68.
21. Dutta AK, Srinivasulu C, Sunanda M, Lakshmi PV, Baratha N. Stem Cell Therapy in Regenerative Medicine Current Progress, Challenges, and Future Prospects. Journal of Neonatal Surgery. 2025;14(6).
22. Tahir F, Tahir A. Regenerative Medicine and Stem Cell Therapy: Advancements and Future Potential. Wah Academia Journal of Health and Nutrition. 2025;1(1):18-29.
23. Dzobo K, Thomford NE, Senthebane DA, Shipanga H, Rowe A, Dandara C, et al. Advances in regenerative medicine and tissue engineering: innovation and transformation of medicine. Stem cells international. 2018;2018(1):2495848.
| Volume | 04 |
| 01 | |
| Received | 17/03/2026 |
| Accepted | 23/03/2026 |
| Published | 03/04/2026 |
| Publication Time | 17 Days |
Login
PlumX Metrics